Amlodipine and Daytime sleep disorder - a phase IV clinical study of FDA data

Summary:

Daytime sleep disorder is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xyrem, and have Cataplexy.

The phase IV clinical study analyzes which people have Daytime sleep disorder when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,808 Amlodipine users. Check the latest studies of Amlodipine.

What is Daytime sleep disorder?

Daytime sleep disorder is found to be associated with 530 drugs and 751 conditions by eHealthMe. Check the latest studies of Daytime sleep disorder.

On Apr, 06, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 28 people (0.01%) have Daytime sleep disorder.

Could Amlodipine cause Daytime sleep disorder?

Among these 28 people:

How long have people been on Amlodipine when they have Daytime sleep disorder? *

What is the gender of people who have Daytime sleep disorder when taking Amlodipine? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Daytime sleep disorder when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

What are other side effects people have besides Daytime sleep disorder? *

Sleep Apnea Syndrome: 6 people, 21.43%
Insomnia (sleeplessness): 5 people, 17.86%
Drowsiness: 4 people, 14.29%
Type 2 Diabetes: 4 people, 14.29%
High Blood Cholesterol: 4 people, 14.29%
Nausea (feeling of having an urge to vomit): 4 people, 14.29%
Pain: 4 people, 14.29%
Loss Of Consciousness: 3 people, 10.71%
Swallowing Difficulty: 3 people, 10.71%
Nasopharyngitis (inflammation of the nasopharynx): 3 people, 10.71%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 17.86%
Sleep Disorder: 4 people, 14.29%
Depression: 3 people, 10.71%
Diabetes: 3 people, 10.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.71%
Drowsiness: 3 people, 10.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.14%
High Blood Cholesterol: 2 people, 7.14%
Epicondylitis (tennis elbow): 2 people, 7.14%
Indigestion: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Daytime sleep disorder?

- Check whether Daytime sleep disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,808 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Daytime sleep disorder:

Daytime sleep disorder (530 drugs)

Browse all the conditions that are associated with Daytime sleep disorder:

Daytime sleep disorder (751 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.